Clinical Trials Directory

Trials / Completed

CompletedNCT01945905

Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in Colombia

Cost-effectiveness of Two Forms of Delivery of Directly Observed Treatment in a Demonstration Area of the DOTS Strategy in Colombia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
264 (actual)
Sponsor
Fundación FES · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Accepted

Summary

* Tuberculosis ( TB ) remains a major global public health problems and actions to ensure the diagnosis and complete treatment of all cases is the priority for the control of this disease. Despite the availability of effective anti-tuberculosis medications, there are still high levels of nonadherence to treatment. The nonadherence increases the morbidity and mortality of patients, decreases the cure rate, increases the community transmission and the increase of chronically ill patients enables the emergence of multi - drug resistant and increases treatment costs. * Despite the knowledge about different forms of cost-effective delivery of DOT (directly observed treatment), recognition of the need to establish the DOT strategy related to the context from local studies, in Colombia and in Cali we hadn't had made studies similar than this one that establish the cost and results of the current DOT delivery strategy and to identify other ways to improve adherence and cure rate for the TB patients at reasonable cost for both: health services and families * Therefore, this research aims to compare the cost -effectiveness of current DOT delivery method with an alternative extra- institutional delivery of anti -TB treatment in urban areas of Cali. A cost-effectiveness study was conducted from the institutional and familiar perspective with prospective information collection.

Detailed description

We compared two strategies for anti- TB treatment delivery: one institutional in which patients went to health institutions to receive treatment and other extra- institutional in which the medication was delivered in the place of choice for treating patients. Measuring the effectiveness ( compliance and cure ) was made from a controlled clinical trial , randomized , partially blinded . The measurement of family and institutional costs , direct and indirect , will be based on the activities.

Conditions

Interventions

TypeNameDescription
OTHERIntramuralUnder this alternative, the patients will receive treatment with direct observation from health team. Treatment will be provided for free
OTHERExtramuralIn this form the medication will be given by a health worker in the place chosen by patients. This option will be delivered to patients with newly diagnosed pulmonary TB without hospitalization criteria

Timeline

Start date
2009-12-01
Primary completion
2014-08-01
Completion
2014-09-01
First posted
2013-09-19
Last updated
2015-08-11

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT01945905. Inclusion in this directory is not an endorsement.